Amniotic Fluid Leakage at 21 Weeks: Risks and Management
Preterm premature rupture of membranes (PPROM) at 21 weeks is a serious obstetric complication. The amniotic sac provides essential protection: cushioning, temperature regulation, infection barrier, and space for fetal movement and lung development.
Immediate Risks
- Infection (chorioamnionitis): Ascending bacteria → maternal sepsis, fetal inflammatory response → preterm labor
- Preterm delivery: Median latency (rupture to delivery) at 21 weeks is ~1-2 weeks; earlier rupture = longer latency but higher morbidity
- Pulmonary hypoplasia: Insufficient fluid → impaired lung development → neonatal respiratory failure
- Cord compression: Oligohydramnios → variable decelerations, fetal distress
- Musculoskeletal deformities: Potter sequence (limb contractures, facial distortion)
Diagnostic Evaluation
- Sterile speculum exam: Pooling, ferning, Nitrazine pH >6.5
- Ultrasound: Amniotic fluid index (AFI), fetal anatomy, growth, placental location
- Maternal monitoring: Temperature, WBC, CRP, fetal heart rate tracing
- Infectious workup: GBS culture, vaginal swabs, amniocentesis (if indicated) for IL-6, glucose, Gram stain
Management at 21 Weeks (Periviable)
| Intervention | Purpose |
|---|---|
| Hospitalization | Close monitoring, immediate intervention capability |
| Antibiotics (latency) | Erythromycin 250mg Q6h ×7d → prolongs pregnancy, reduces chorioamnionitis, neonatal sepsis |
| Antenatal corticosteroids | Betamethasone 12mg IM q24h ×2 (at 23+0 to 23+6 weeks per guidelines; individualized at 21-22 weeks) |
| Magnesium sulfate | Neuroprotection if delivery imminent <32 weeks |
| Tocolytics | Short-term (48h) to allow steroid completion; contraindicated with infection |
| Serial ultrasounds | AFI, growth, Doppler, fetal well-being |
